GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Long-Term Debt

Q2M Biotech AG (HAM:QBI) Long-Term Debt : €0.00 Mil (As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Long-Term Debt?

Q2M Biotech AG's Long-Term Debt for the quarter that ended in . 20 was €0.00 Mil.


Q2M Biotech AG Long-Term Debt Historical Data

The historical data trend for Q2M Biotech AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Long-Term Debt Chart

Q2M Biotech AG Annual Data
Trend
Long-Term Debt

Q2M Biotech AG Quarterly Data
Long-Term Debt

Q2M Biotech AG  (HAM:QBI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Q2M Biotech AG Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines